The building blocks of successful translation of proteomics to the clinic.
The building blocks of successful translation of proteomics to the clinic.
复制标题
DOI:
10.1016/j.copbio.2017.12.011
复制
发表时间:
2018-06
影响因子:
7.7
通讯作者:
Hood L
中科院分区:
文献类型:
--
作者:
Kearney P;Boniface JJ;Price ND;Hood L
Recently, the first two multiplexed tests using selective reaction monitoring (SRM-MS) mass spectrometry have entered clinical practice. Despite different areas of indication, risk stratification in lung cancer and preterm birth, they share multiple steps in their development strategies. Here we review these strategies and their implications for successful translation of biomarkers to clinical practice. We believe that the identification of blood protein panels for the identification of disease phenotypes is now a reproducible and standard (albeit complex) process.
登录
查看更多内容
影响因子:
5
作者:
Vachani A;Hammoud Z;Springmeyer S;Cohen N;Nguyen D;Williamson C;Starnes S;Hunsucker S;Law S;Li XJ;Porter A;Kearney P
通讯作者:
Kearney P
影响因子:
9.3
作者:
Ellington AA;Kullo IJ;Bailey KR;Klee GG
通讯作者:
Klee GG
DOI:
10.1371/currents.rrn1249
发表时间:
2011-07-21
期刊:
PLoS currents
影响因子:
--
作者:
Ishibe, Naoko;Schully, Sheri;Ramsey, Scott David
通讯作者:
Ramsey, Scott David
影响因子:
2.8
作者:
Eddy JA;Sung J;Geman D;Price ND
通讯作者:
Price ND
影响因子:
5.4
作者:
Gold, Larry;Walker, Jeffrey J.;Williams, Stephen
通讯作者:
Williams, Stephen